Form 4 for ONC BeOne Medicines Ltd.
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-17 · accession 0001651308-22-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-19 | 2022-05-17 | ONC | Wang Lai | Gbl Head of R, D | M - OptEx | $3.26 | +1.23M | 1.41M | +707% | +$4.03M |
| DM | 2022-05-19 | 2022-05-17 | ONC | Wang Lai | Gbl Head of R, D | M - OptEx | $0.00 | -1.23M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-05-17 | M | A | 233,948 | $2.29 | 408,499 | D | — | — | |
| 2 | Common | Ordinary Shares | 2022-05-17 | M | A | 999,999 | $3.49 | 1,408,498 | D | — | — | |
| 3 | Derivative | Share Option (Right to Buy) | 2022-05-17 | M | D | 999,999 | $0.00 | 0 | D | $3.49 · — to 2027-06-26 | 999,999 Ordinary Shares | (F6) Fully vested on June 30, 2021. |
| 4 | Derivative | Share Option (Right to Buy) | 2022-05-17 | M | D | 233,948 | $0.00 | 0 | D | $2.29 · — to 2026-07-13 | 233,948 Ordinary Shares | (F5) Fully vested on July 31, 2020. |